If you are unemployed or furloughed, 202 7488000. If you visited a food bank, 202 7488001 is the number. If you are behind on a housing payment, 202 7488002. All others this morning, 202 7488003. That is also the number you can send us a text this morning. Send a text, include your name and where you are from. Otherwise, catch up with us on social media. On facebook, it is facebook. Com cspan. You can start calling in and this first section of the washington journal. In in this first section of the wafted in journal. This week is said to be a crucial one. Now,rn to eric watson congressional reporter for bloomberg. Good morning to you. What is the status of negotiations . Did anything change over the weekend . Guest good morning, john. Yes, over the weekend, this gang of eight senators, for democrats and four republicans four democrats and four republicans, had a series of meetings to develop a text on their bipartisan proposal. A week ago, an at least in outline. At least an outline. T
Riots break out in several u. S. Cities between left wing groups on supporters leading to stopping. Them exposing a deepening rift. With the top stories from the past 7 days on right up to the moment of elements as well this is the weekly on our to International Hello and welcome. Russian british scientists have agreed to combine forces on their vaccines in a bid to tackle the Global Pandemic astra zeneca says its ready to work with the developers of russias. Job. Today we announce a Clinical Trial program to assess safety and immunogenicity of combination of as a d 1222 developed by astra zeneca and Oxford University and sputnik v. Developed by Russian Research institute the Vaccine Developers hope that combining their drugs could lead to a better and unit response to the corona virus the Clinical Trials will be held in russia and involved volunteers aged 18 and over the job created by Oxford University and astra zeneca meanwhile has shown varying results depending on the dose with an
To the scale ability on to the manufacturing and crimes and assessment, which is really a big advantage given the unprecedented need we are having. And the moment and last year i would like to highlight that also as an eco and oxford, a vaccine is also part of callbacks, which is an initiative by the savvy and the little actual to really make the Vaccines Available for low and middle income countries. So i think this is certainly a plus b. That we always been saying, unless not everybody is not safe, nobody is safe. How quickly can be rolled obvious thing that either has ordered that the doctor that is because entered now today morning is really they intervene. So we have to wait for the full data to become available and that would be presented to the regular people. Easier is called how much are they . And once that is approved, i think the anticipation is by mid december. We will have the a cool and probably rolling out into the Frontline Health workers and also care home, which is n
You cant have to leave genes, you can have closes but not to genes. So this means that the efficacy is either 60 percent or 90 percent depending which does it take, but whatever the build they will choose, need to be fine tuned and we tested before to fall into the market. Now obviously weve heard this is the 3rd promising vaccine that has been announced in the fight against a covert. 90 weve heard of course from the vaccine from biotech and pfizer mcgurn, are russias sputnik obviously, also supposedly very effective on so many vaccines in the pipeline. You know, is there a rivalry there . Is there a competition, there . Is this good bad . Is there room for all of them . Well, this is really important question and to be honest, if this is a business for pharmaceutical being very clear, and this is certainly a market, for example, if you remember deferred wiser c. E. O. , it clearly stated that they are not going to subsidize any vaccine, just because thats not in favor of the company,
Absolutely. I think one of the concerns that we are having now and kind of here being debated is a vote. The efficacy. Because the efficacy of that to me of being calculated is that one of those in the team has 60 percent and other has 90 percent. And then they took the average of 70, but basically you cant really say 70 because only person can get one regina, you point have to be genes. You can have 2 doses, but not to have genes. So this means that the efficacy is either 60 percent or 90 percent depending which of those it takes, but whatever the build they will choose, need to be fine tuned and we tested 40 people into the market. Now obviously weve heard this is the 3rd promising vaccine that has been announced in the fight against a covert. 90 weve heard of course, from the vaccine, from biotech and fice or modern are russias sputnik obviously, also supposedly very effective on so many vaccines in the pipeline. You know, is there a rivalry there . Is there a competition, there is